CannaGrow Bioscience aims to become a major producer of Hemp CBD with its Reverse Nature brand, and with global progressive legalization of Cannabis, utilize both Hemp and Marijuana CBD, for producing “ailment specific” products aimed at Tinnitus, Menopause and more, that will differ Reverse Nature from ”other” Cannabidiol’s produced.
Cannabis is the new buzzword integrating into everything around us. In 2015 ~237 million people used Cannabis. Countries worldwide are legalizing Cannabis for both medical and recreational uses. Medical Cannabis is used mostly for alleviating indications, such as: pain, Nausea, MS, Paraplegia, Depression, Anxiety, Psychosis, Glaucoma, Tourette, Alzheimer’s, Parkinson’s and Cancer.
The best-known cannabis compound is THC, which creates the “high”. Lately Cannabidiol or “CBD” has made a significant increase in demand due to its health benefits. CBD comes from two main sources, Marijuana or Hemp derived, which is legal in many countries. The CBD market is projected to surpass $20b by 2024, with a CAGR of 31% and 80% of the growth coming from the Americas.
CannaGrow Bioscience look to raise £2.5m investment via a common share offering at a pre-money valuation of £7.5m.
